Long-term ethanol exposure causes human liver cancer cells to become resistant to mitomycin c treatment through the inactivation of bad-mediated apoptosis

Ching Shui Huang, Yi Ru Lee, Ching Shyang Chen, Shih Hsin Tu, Ying Jan Wang, Chia Hwa Lee, Li Ching Chen, Hui Wen Chang, Chien Hsi Chang, Chih-Ming Su, Chih Hsiung Wu, Yuan Soon Ho

研究成果: 雜誌貢獻文章

4 引文 (Scopus)

摘要

The aim of this study was to test whether long-term ethanol consumption confers therapeutic resistance to human liver cancer patients infected with hepatitis B virus (HBV). Chronic ethanol-treated cells were established by consecutively culturing a human hepatocellular carcinoma cell line, Hep 3B, which contains integrated HBV sequences, for 20-40 passages with or without 10mM ethanol (designated as E20-E40 and C20-C40, respectively). Flow cytometry analysis demonstrated that a growth promoting effect of long-term ethanol treatment was induced in the E40 cells through preferential acceleration of S-phase in these cells. Lower protein expression levels of p16, p21/Cip1, and p27/Kip1 were detected in the ethanol-treated E40 cells. We further demonstrated that long-term ethanol-treated E40 cells develop drug resistance in response to mitomycin C (MMC) treatment (>8 μM). Immunoblot analysis revealed that caspase-8-mediated mitochondrial apoptotic signals (such as Bad) were inactivated in the MMC-resistant E40 cells. Immunoprecipitation experiments demonstrated that the sequestration of phosphorylated Bad (Ser-112) through its binding with 14-3-3 was detected more profoundly in the MMC-resistant E40 cells. Next, we examined the therapeutic efficacy of MMC (10mg MMC/kg body weight, three times per week) in severe combined immunodeficient (SCID) mice bearing E40- and C40-xenografted tumors. Significant reductions (>3-fold) in tumor growth were detected in MMC-treated C40-xenografted mice. In vivo and in vitro studies demonstrated that AKT-and extracellular signal-regulated kinase (ERK)-mediated survival factors inhibited the Bad-induced mitochondrial apoptotic signals that were involved in E40 tumor cells and that conferred resistance to MMC.
原文英語
頁(從 - 到)728-738
頁數11
期刊Molecular Carcinogenesis
49
發行號8
DOIs
出版狀態已發佈 - 八月 2010

指紋

Mitomycin
Liver Neoplasms
Ethanol
Apoptosis
Therapeutics
Hepatitis B virus
Neoplasms
SCID Mice
Caspase 8
Extracellular Signal-Regulated MAP Kinases
Growth
S Phase
Immunoprecipitation
Drug Resistance
Hepatocellular Carcinoma
Flow Cytometry
Body Weight
Cell Line
Survival

ASJC Scopus subject areas

  • Cancer Research
  • Molecular Biology

引用此文

Long-term ethanol exposure causes human liver cancer cells to become resistant to mitomycin c treatment through the inactivation of bad-mediated apoptosis. / Huang, Ching Shui; Lee, Yi Ru; Chen, Ching Shyang; Tu, Shih Hsin; Wang, Ying Jan; Lee, Chia Hwa; Chen, Li Ching; Chang, Hui Wen; Chang, Chien Hsi; Su, Chih-Ming; Wu, Chih Hsiung; Ho, Yuan Soon.

於: Molecular Carcinogenesis, 卷 49, 編號 8, 08.2010, p. 728-738.

研究成果: 雜誌貢獻文章

@article{d98c2586cd7541038cff4cb9c18ee5a5,
title = "Long-term ethanol exposure causes human liver cancer cells to become resistant to mitomycin c treatment through the inactivation of bad-mediated apoptosis",
abstract = "The aim of this study was to test whether long-term ethanol consumption confers therapeutic resistance to human liver cancer patients infected with hepatitis B virus (HBV). Chronic ethanol-treated cells were established by consecutively culturing a human hepatocellular carcinoma cell line, Hep 3B, which contains integrated HBV sequences, for 20-40 passages with or without 10mM ethanol (designated as E20-E40 and C20-C40, respectively). Flow cytometry analysis demonstrated that a growth promoting effect of long-term ethanol treatment was induced in the E40 cells through preferential acceleration of S-phase in these cells. Lower protein expression levels of p16, p21/Cip1, and p27/Kip1 were detected in the ethanol-treated E40 cells. We further demonstrated that long-term ethanol-treated E40 cells develop drug resistance in response to mitomycin C (MMC) treatment (>8 μM). Immunoblot analysis revealed that caspase-8-mediated mitochondrial apoptotic signals (such as Bad) were inactivated in the MMC-resistant E40 cells. Immunoprecipitation experiments demonstrated that the sequestration of phosphorylated Bad (Ser-112) through its binding with 14-3-3 was detected more profoundly in the MMC-resistant E40 cells. Next, we examined the therapeutic efficacy of MMC (10mg MMC/kg body weight, three times per week) in severe combined immunodeficient (SCID) mice bearing E40- and C40-xenografted tumors. Significant reductions (>3-fold) in tumor growth were detected in MMC-treated C40-xenografted mice. In vivo and in vitro studies demonstrated that AKT-and extracellular signal-regulated kinase (ERK)-mediated survival factors inhibited the Bad-induced mitochondrial apoptotic signals that were involved in E40 tumor cells and that conferred resistance to MMC.",
keywords = "Apoptosis, Bad phosphorylation, Ethanol consumption, Liver cancer, Mitomycin C",
author = "Huang, {Ching Shui} and Lee, {Yi Ru} and Chen, {Ching Shyang} and Tu, {Shih Hsin} and Wang, {Ying Jan} and Lee, {Chia Hwa} and Chen, {Li Ching} and Chang, {Hui Wen} and Chang, {Chien Hsi} and Chih-Ming Su and Wu, {Chih Hsiung} and Ho, {Yuan Soon}",
year = "2010",
month = "8",
doi = "10.1002/mc.20648",
language = "English",
volume = "49",
pages = "728--738",
journal = "Molecular Carcinogenesis",
issn = "0899-1987",
publisher = "Wiley-Liss Inc.",
number = "8",

}

TY - JOUR

T1 - Long-term ethanol exposure causes human liver cancer cells to become resistant to mitomycin c treatment through the inactivation of bad-mediated apoptosis

AU - Huang, Ching Shui

AU - Lee, Yi Ru

AU - Chen, Ching Shyang

AU - Tu, Shih Hsin

AU - Wang, Ying Jan

AU - Lee, Chia Hwa

AU - Chen, Li Ching

AU - Chang, Hui Wen

AU - Chang, Chien Hsi

AU - Su, Chih-Ming

AU - Wu, Chih Hsiung

AU - Ho, Yuan Soon

PY - 2010/8

Y1 - 2010/8

N2 - The aim of this study was to test whether long-term ethanol consumption confers therapeutic resistance to human liver cancer patients infected with hepatitis B virus (HBV). Chronic ethanol-treated cells were established by consecutively culturing a human hepatocellular carcinoma cell line, Hep 3B, which contains integrated HBV sequences, for 20-40 passages with or without 10mM ethanol (designated as E20-E40 and C20-C40, respectively). Flow cytometry analysis demonstrated that a growth promoting effect of long-term ethanol treatment was induced in the E40 cells through preferential acceleration of S-phase in these cells. Lower protein expression levels of p16, p21/Cip1, and p27/Kip1 were detected in the ethanol-treated E40 cells. We further demonstrated that long-term ethanol-treated E40 cells develop drug resistance in response to mitomycin C (MMC) treatment (>8 μM). Immunoblot analysis revealed that caspase-8-mediated mitochondrial apoptotic signals (such as Bad) were inactivated in the MMC-resistant E40 cells. Immunoprecipitation experiments demonstrated that the sequestration of phosphorylated Bad (Ser-112) through its binding with 14-3-3 was detected more profoundly in the MMC-resistant E40 cells. Next, we examined the therapeutic efficacy of MMC (10mg MMC/kg body weight, three times per week) in severe combined immunodeficient (SCID) mice bearing E40- and C40-xenografted tumors. Significant reductions (>3-fold) in tumor growth were detected in MMC-treated C40-xenografted mice. In vivo and in vitro studies demonstrated that AKT-and extracellular signal-regulated kinase (ERK)-mediated survival factors inhibited the Bad-induced mitochondrial apoptotic signals that were involved in E40 tumor cells and that conferred resistance to MMC.

AB - The aim of this study was to test whether long-term ethanol consumption confers therapeutic resistance to human liver cancer patients infected with hepatitis B virus (HBV). Chronic ethanol-treated cells were established by consecutively culturing a human hepatocellular carcinoma cell line, Hep 3B, which contains integrated HBV sequences, for 20-40 passages with or without 10mM ethanol (designated as E20-E40 and C20-C40, respectively). Flow cytometry analysis demonstrated that a growth promoting effect of long-term ethanol treatment was induced in the E40 cells through preferential acceleration of S-phase in these cells. Lower protein expression levels of p16, p21/Cip1, and p27/Kip1 were detected in the ethanol-treated E40 cells. We further demonstrated that long-term ethanol-treated E40 cells develop drug resistance in response to mitomycin C (MMC) treatment (>8 μM). Immunoblot analysis revealed that caspase-8-mediated mitochondrial apoptotic signals (such as Bad) were inactivated in the MMC-resistant E40 cells. Immunoprecipitation experiments demonstrated that the sequestration of phosphorylated Bad (Ser-112) through its binding with 14-3-3 was detected more profoundly in the MMC-resistant E40 cells. Next, we examined the therapeutic efficacy of MMC (10mg MMC/kg body weight, three times per week) in severe combined immunodeficient (SCID) mice bearing E40- and C40-xenografted tumors. Significant reductions (>3-fold) in tumor growth were detected in MMC-treated C40-xenografted mice. In vivo and in vitro studies demonstrated that AKT-and extracellular signal-regulated kinase (ERK)-mediated survival factors inhibited the Bad-induced mitochondrial apoptotic signals that were involved in E40 tumor cells and that conferred resistance to MMC.

KW - Apoptosis

KW - Bad phosphorylation

KW - Ethanol consumption

KW - Liver cancer

KW - Mitomycin C

UR - http://www.scopus.com/inward/record.url?scp=77956135374&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77956135374&partnerID=8YFLogxK

U2 - 10.1002/mc.20648

DO - 10.1002/mc.20648

M3 - Article

C2 - 20623640

AN - SCOPUS:77956135374

VL - 49

SP - 728

EP - 738

JO - Molecular Carcinogenesis

JF - Molecular Carcinogenesis

SN - 0899-1987

IS - 8

ER -